FIELD: medicine.
SUBSTANCE: invention concerns to a derivative of formulas (I) and to its application as an inhibitor of human sodium-dependent glucose transporter (SGLT) for treating the diseases associated with hyperglycemia: , where A1 is O or S; A2 is CH or N; R1 or R4 is a group of formula (S):
, where R5, R6 are hydrogen, hydroxyl, halogen, alkyl, alkoxy-, alkylthio; Q is alkylene, alkenylene, alkylene-O- alkylen-S-, -O-alkylene-, -S-alkylene-, alkylene-O-alkylene, -alkylene-S-alkylene-; A is phenyl; R2, R3 - hydrogen; G is group of formulae:
or
E1 - hydrogen, fluorine, hydroxyl; E2 - hydrogen, fluorine, methyl, hydroxymethyl.
EFFECT: production of new inhibitors of human SGLT.
15 cl, 17 ex, 7 tbl
Title | Year | Author | Number |
---|---|---|---|
DERIVATIVES OF GLUCOPYRANOSYLOXYPYRAZOLE AND THEIR USING IN MEDICINAL AGENTS | 2001 |
|
RU2317302C2 |
PYRAZOLE DERIVATIEVES, MEDICAL COMPOSITIONS, CONTAINING SAID DERIVATIVES, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR OBTAINING | 2003 |
|
RU2356906C2 |
BENZYLPHENYLCYCLOHEXANE DERIVATIVES AND METHODS OF THEREOF APPLICATION | 2008 |
|
RU2505521C2 |
PYRAZOL DERIVATIVES, MEDICAL COMPOSITIONS, CONTAINING THEM, THEIR APPLICATION IN MEDICINE AND INTERMEDIATE COMPOUNDS FOR THEIR PRODUCTION | 2003 |
|
RU2369613C2 |
DERIVATIVES OF ARYL-5-THIO-β-D-GLYCOPYRANOSIDE AND THERAPEUTIC AGENT COMPRISING THEREOF USED IN DIABETES MELLITUS | 2003 |
|
RU2322449C2 |
METHOD OF PRODUCING SGLT2 INHIBITORS | 2009 |
|
RU2530494C2 |
ROR-GAMMA MODULATORS | 2012 |
|
RU2658013C2 |
NEW GLUCITOL DERIVATIVE, PRODRUG AND SALT AND THERAPEUTIC AGENT CONTAINING THEM FOR DIABETES TREATMENT | 2005 |
|
RU2386631C2 |
SPIROKETAL DERIVATIVES AND USE THEREOF AS MEDICINAL AGENT AGAINST DIABETES | 2006 |
|
RU2416617C2 |
CRYSTALLINE FORMS OF COMPLEXES USEFUL AS SGLT2 INHIBITORS, AND METHODS OF THEIR OBTAINING | 2014 |
|
RU2641905C2 |
Authors
Dates
2010-04-27—Published
2005-03-03—Filed